Biotech & Life Sciences
Pulsenmore Validates U.S. Market Demand With New Maternal‑Fetal Partnership
Home Ultrasound Gains Traction Among U.S. Maternal-Fetal Medicine Practices Pulsenmore has secured another commercial engagement in the United States, continuing to build momentum following recent FDA clearance of its home ultrasound technology. The latest agreement brings Pulsenmore’s Early Screening home ultrasound services into TLC Perinatal PA, a maternal-fetal medicine and women’s ultrasound practice operating in…
Innovent and Lilly Launch Breakthrough $8.5B Global Drug Collaboration
Innovent Biologics has entered into a new strategic collaboration with Eli Lilly aimed at developing next-generation medicines for cancer and immune-related diseases, deepening a partnership that has spanned more than a decade. The agreement represents the seventh collaboration between the two companies and introduces a development model designed to accelerate Innovent’s pipeline from early discovery…
Azitra Extends Timeline as Shareholder Meeting Reconvenes in Early March
AZTR performance by TradingView Azitra, Inc. (NYSE AMERICAN: AZTR) has adjourned its recently convened special shareholder meeting after failing to reach the minimum quorum required to proceed with voting. The meeting is now scheduled to reconvene on March 6, 2026, giving the company additional time to solicit shareholder participation on key corporate proposals. At the…
10x Genomics Partners with PharosAI to Build Breakthrough AI‑Ready Cancer Datasets
TXG performance by TradingView Strategic Partnership Announcement 10x Genomics, Inc. (Nasdaq: TXG) announced that PharosAI, a UK research consortium, will use its Xenium spatial platform to create one of the world’s most comprehensive multimodal cancer datasets. Backed by £18.9 million from the UK Government’s Research Ventures Catalyst and additional support from charities and industry partners,…
15 Cities, One Goal: Antlara Dental’s Personalized European Consultations
Introducing In‑Person Dental Consultations Across EuropeAntlara Dental is launching a new series called Let’s Talk Smiles – Face to Face to offer people direct, in‑person access to dental professionals across Europe. These events are designed to help individuals plan dental care with confidence by connecting them to experienced dentists before any treatment decisions. Expanding Engagement…
Investors Eye Proteins Market: 9.5% Annual Growth Through 2030
Executive Summary The proteins and protein crystals market has become one of the most important pillars of modern biotechnology and biopharmaceuticals. Growth is being driven by rising demand for therapeutic proteins, advances in structural biology, and expanding use across healthcare, agriculture, food processing, and industrial applications. According to MarketsandMarkets, the market is expected to grow…
Sephora Welcomes AESTURA’s Fastest-Growing Redness-Reducing Skincare Line
AESTURA, Korea’s top dermatologist-recommended dermocosmetic brand for sensitive skin, has announced the launch of A-CICA365, a three-product collection designed to soothe skin and visibly reduce redness. The new collection expands AESTURA’s partnership with Sephora and will be available in all Sephora stores nationwide throughout 2026. Growing U.S. Demand Since entering Sephora in February 2025, AESTURA…
Facial Injectables Dominate 55% of the Market: Botox, Fillers, and Skin Rejuvenation on the Rise
Executive Summary The global medical aesthetics market is growing quickly. Rising demand for minimally invasive and non-surgical treatments, combined with new technology in injectables and energy-based devices, is driving expansion. Consumers are more comfortable than ever with aesthetic procedures, influenced by social media, lifestyle trends, and an aging population. MarketsandMarkets projects the market to grow…
FDA Clears First Nerve-Specific Fluorescent Agent for Human Trials
Trace Biosciences, Inc., a clinical-stage biotechnology company focused on nerve-targeted imaging, announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for LGW16-03, the company’s first nerve-specific fluorescent imaging agent. This clearance allows Trace to begin first-in-human studies to assess the safety and performance of LGW16-03 during surgery. Helping…
Paytient’s Innovative Payment Solutions Earn Top Recognition in 2025
Paytient, a leader in healthcare affordability and payment solutions, was recognized with Modern Healthcare’s 2025 Best in Business Award in the Patient Experience and Engagement category. The award underscores Paytient’s role as a critical infrastructure partner for insurers and employers, helping bridge the gap between health coverage and access, particularly through the company’s Medicare Prescription…
